PERSPECTA

News from every angle

← Back to headlines

Boston Scientific's SEISMIQ 4CE Succeeds in Coronary Artery Disease Trial

Boston Scientific announced that its SEISMIQ 4CE device successfully completed trials for treating coronary artery disease.

19 May, 11:47 — 19 May, 11:47
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed35d ago

Boston Scientific’s SEISMIQ 4CE succeeds in trial for coronary artery disease

Read full article →

Related Stories

Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk

just now

StanChart hosts inaugural digital assets summit in Accra

13m ago

China Now Home to the World's Fastest Supercomputer

23m ago

Anthropic Launches Claude Tag Research Preview for Slack Users

23m ago